ONKURE THERAPEUTICS, INC.
Profile
Company Names
ONKURE THERAPEUTICS, INC.
RENEO PHARMACEUTICALS, INC.
Addresses
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO 80301
12230 EL CAMINO REAL, SUITE 230, SAN DIEGO, CA 92130
12730 HIGH BLUFF DRIVE, SUITE 160, SAN DIEGO, CA 92130
Phone Numbers
(720) 307-2892
858-283-0280
858-346-1755
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2014
State Incorporated:
DELAWARE
Total Amount Raised:
$159,379,683.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2024-10-04
$65,000,000.00
$65,000,000.00
$0.00
Equity
3
2020-12-09
$47,384,999.00
$94,769,998.00
$47,384,999.00
Equity
2
2019-05-01
$25,000,002.00
$25,000,002.00
$0.00
Equity
1
2017-12-22
$21,994,682.00
$51,994,684.00
$30,000,002.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL
GREY
EXECUTIVE OFFICER, DIRECTOR
AUSPEX PHARMACEUTICALS, INC.
| ACHILLION PHARMACEUTICALS INC
| LUMENA PHARMACEUTICALS, INC.
| SELVENTA, INC.
| HORIZON PHARMA, INC.
| BALANCE THERAPEUTICS, INC.
| AMPLYX PHARMACEUTICALS, INC.
| RENEO PHARMACEUTICALS, INC.
| MIRUM PHARMACEUTICALS, INC.
| SPRUCE BIOSCIENCES, INC.
| SORRISO PHARMACEUTICALS, INC.
| PLEXIUM, INC.
KENNETH
HARRISON
DIRECTOR
JASON
LEVERONE
EXECUTIVE OFFICER
ED
MATHERS
DIRECTOR
LIQUIDIA TECHNOLOGIES INC
| INTARCIA THERAPEUTICS, INC
| ENVISIA THERAPEUTICS INC.
| SYNLOGIC, INC.
| MIRNA THERAPEUTICS, INC.
| AMPLYX PHARMACEUTICALS, INC.
| ENVISIA THERAPEUTICS, INC.
| SYNLOGIC, LLC
| TREVI THERAPEUTICS, INC.
| AKOUOS, INC.
| RENEO PHARMACEUTICALS, INC.
| SENTI BIOSCIENCES, INC.
| MIRUM PHARMACEUTICALS, INC.
| CURZION PHARMACEUTICALS, INC.
EDWARD
T.
MATHERS
DIRECTOR
RHYTHM METABOLIC, INC.
| RHYTHM PHARMACEUTICALS, INC.
| NEA BH SPV, L.P.
| NEA BH SPV II, L.P.
| MIRUM PHARMACEUTICALS, INC.
| NEW ENTERPRISE ASSOCIATES 18, L.P.
| NEA 18 VENTURE GROWTH EQUITY, L.P.
| NEA SH SPV, L.P.
| NEA RP SPV, L.P.
| NEA CH SPV, L.P.
| NEA TS 2024 SPV, L.P.
| NEA SECONDARY OPPORTUNITY FUND, L.P.
| ONKURE THERAPEUTICS, INC.
NIALL
O-DONNELL
EXECUTIVE OFFICER, DIRECTOR
LYRIC PHARMACEUTICALS INC.
| 3X5 RIVERVEST FUND II, L.P.
| ARCHER SEED FUND, L.P.
| GENOA PHARMACEUTICALS, INC.
| RENEO PHARMACEUTICALS, INC.
| RIVERVEST VENTURE FUND IV, L.P.
| CURZION PHARMACEUTICALS, INC.
| SPRUCE BIOSCIENCES, INC.
| AVALYN PHARMA INC.
| MIRUM PHARMACEUTICALS, INC.
| RIVERVEST VENTURE FUND V, L.P.
| SPARROW PHARMACEUTICALS, INC.
| WUGEN, INC.
NICHOLAS
SACCOMANO
EXECUTIVE OFFICER, DIRECTOR
STACEY
SELTZER
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-10-04

